Conclusion
Our findings reveal that empagliflozin inhibited chondrocytes ECM degradation, inflammation and cellular senescence in vitro and prevented cartilage degeneration in vivo by suppressing NF-κB signal pathway, indicating a therapeutic potential in OA treatment.
Keywords: empagliflozin; chondrocyte; inflammation; senescence; NF-κB.